PRODEGY
LIVE

Serial Number

97252411

Owner

BioTheryX, Inc.

Attorney

Stacey R. Halpern

Filing Date

Feb 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PRODEGY Trademark

Serial Number: 97252411

PRODEGY is a trademark filed by BioTheryX, Inc. on February 3, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

BioTheryX, Inc. (15 trademarks)

7966 Arjons Drive, Suite D
San Diego, CA 92126

Entity Type: 03

Trademark Details

Filing Date

February 3, 2022

Registration Date

Not Registered

Goods & Services

Testing, inspection, research, or development of pharmaceutical preparations; providing an on-line searchable database in the field of pharmaceutical preparations for degrading protein levels to treat diseases related to aberrant protein expression for scientific research purposes; drug screening for scientific research purposes; medical laboratory services; genetic testing for scientific research purposes; providing an on-line searchable database featuring protein molecules for scientific research purposes; providing on-line non-downloadable software program for use in the discovery and development of targeted proteins used to develop treatments for diseases; providing on-line non-downloadable software program for use in the discovery and development of targeted proteins used to develop medicines; providing on-line non-downloadable software program for identifying, searching, and screening protein molecules; providing on-line non-downloadable software program for searching within a library of protein molecules; providing medical and scientific research information; consulting services in the field of genetic science

Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, pharmaceutical preparations for degrading protein levels to treat diseases related to aberrant protein expression; pharmaceutical preparations for restoring protein levels to treat diseases related to aberrant protein expression; protein arrays for medical diagnosis purposes

Medical services; providing an on-line searchable database in the field of pharmaceutical preparations for degrading protein levels to treat diseases related to aberrant protein expression; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing information in the field of medicine or cancer treatment and diagnosis; providing medical information; drug screening for medical purposes; genetic testing for medical purposes; genetic counseling

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 15, 2026 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 15, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 15, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 14, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 13, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 12, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 12, 2024 GNSL
SUSPENSION LETTER WRITTEN
Dec 12, 2024 CNSL
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 7, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 24, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 23, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 23, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jan 23, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 9, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 9, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 9, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 9, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 9, 2022 CNRT
ASSIGNED TO EXAMINER
May 25, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2022 NWOS
NEW APPLICATION ENTERED
Feb 7, 2022 NWAP